Stay informed with the latest litigation news. Explore now

IP Verse

Dr Falk Pharma competitive analysis

Latest publications and patents of Dr Falk Pharma New

Explore the latest publications and patents granted to Dr Falk Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 12, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Dr Falk Pharma

EP2886108
Nov 2, 2022Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The EsophagusPatent Maintained As Amended
EP3086782
Sep 26, 2018Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The EsophagusOpposition Rejected

Latest oppositions filed by Dr Falk Pharma

Explore patent oppositions filed by Dr Falk Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3574914
Corticosteroid CompositionsMERITAGE PHARMASep 1, 2022
EP2585075
Methods Of Treatment For Esophageal InflammationMERITAGE PHARMAMay 4, 2022
EP2646003
Rapidly Dispersing Granules, Orally Disintegrating Tablets And MethodsADARE PHARMACEUTICALSFeb 23, 2021
EP3354276
Compositions For The Treatment Of Gastrointestinal InflammationMERITAGE PHARMASep 23, 2020
EP3041476
Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic EsophagitisADARE IJul 22, 2020
EP3403654
Orally Administered Corticosteroid CompositionsADARE IApr 28, 2020
EP2214679
Corticosteroid CompositionsMERITAGE PHARMADec 19, 2019
EP2482822
Orally Administered Corticosteroid CompositionsADARE IMar 1, 2019
EP2211896
Compositions For The Treatment Of Gastrointestinal InflammationMERITAGE PHARMASep 27, 2018
EP2214677
Compositions For The Treatment Of Inflammation Of The Gastrointestinal TractMERITAGE PHARMAMay 22, 2018

Latest patents of Dr Falk Pharma opposed by its competitors

Explore Dr Falk Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2886108
Nov 2, 2022Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The Esophagus1
EP3086782
Sep 26, 2018Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus1

Latest PTAB cases involving Dr Falk Pharma New

Discover the latest PTAB cases involving Dr Falk Pharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 18, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Dr Falk Pharma

IPR2025-00056Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTrial Instituted
IPR2025-00055Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTrial Instituted
IPR2025-00054Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTrial Instituted
IPR2025-00052Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTrial Instituted
IPR2024-01197Jul 22, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTrial Instituted